LCID UT (@CIDatUT) header
LCID UT (@CIDatUT) profile picture

Research Center at University of Texas specializing in infectious disease

Austin, Texas
Joined May 2014
Photo by LCID UT (@CIDatUT)Photo by LCID UT (@CIDatUT)Photo by LCID UT (@CIDatUT)Photo by LCID UT (@CIDatUT)Photo by LCID UT (@CIDatUT)Photo by LCID UT (@CIDatUT)Photo by LCID UT (@CIDatUT)Photo by LCID UT (@CIDatUT)Photo by LCID UT (@CIDatUT)Photo by LCID UT (@CIDatUT)
Hantaviruses kill nearly 40% of those infected and there’s no approved treatment or vaccine, making them a concern for future pandemics. The most detailed 3D map yet of a key protein complex on the virus might yield new treatments. cns.utexas.edu/news/research…
1
1
196
A message from Interim President Jim Davis: “It’s been a tragic week in Texas. We deeply mourn the loss of so many lives from the hill country floods and pray for all who are impacted. We are also grateful for those working tirelessly to help and the many lives they have saved. As Longhorns, we pause to remember those lost, take stock of our many blessings, and continue to do our part to care for those affected.”
11
93
5
520
159,633
Check out @TexasChE Professor Lydia Contreras, @Contreras_Lab, in #ItStartsWithResearch premiere episode from @UTexasResearch. @CockrellSchool
In the debut episode of our #ItStartsWithResearch series, @CockrellSchool chem eng. prof. Lydia Contreras discusses how exciting it is to transform lives – and how @UTAustin helps her do it. P.S. Love the scarf, Professor! @Contreras_Lab @TexasChE #TexasResearch #WhatStartsHere
3
7
1,186
. @ut_mbs is excited to host the @WelchFoundation Emerging Leaders in Chemistry Visitor Series from 12 – 1 pm on Sept 6. Dr. Vinayak Agarwal will explore engineering natural product biosynthesic pathways. RSVP: bit.ly/3PgDPWk
4
6
656
In aggregate, solid evidence that the bivalent booster elicits a strong and broadened neutralizing antibody immune response. Yet, less than 27% of Americans 65+, the have had it and poor uptake across all age groups covid.cdc.gov/covid-data-tra…
13
75
7
196
As a founding member, I'm deeply grateful for the philanthropic generosity of the Texas Exes who were pivotal in catalyzing the launch of Texas Biologics—a unique translational medicine initiative at UT Austin. Heavy lifting by @McLellan_Lab, George Georgiou, and @matouschek.
1
3
The National Science Foundation @NSF has selected The University of Texas at Austin for a pilot grant to establish the Center for Pandemic Decision Science (CPDS) @NSF #NSFfunded @UTPandemics @TexasScience @MeyersLab https://teapawt.net/t.co/7Z2ZVpIkqA
1
9
5
30
Proud to be an official depositor @NCTC_3000. Our E. coli K-12 strains expressing mobile colistin resistance (MCR) proteins are available there for anyone that needs to use them. #AMR journals.asm.org/doi/10.1128…
1
5
25
The Biden administration plans to offer updated coronavirus booster shots to Americans 12 and older soon after Labor Day. nyti.ms/3TfD8fA
1
3
4
Check out our manuscript reporting the structure of the αMβ2 integrin bound to the adenylate cyclase toxin from B. pertussis! cell.com/cell-reports/fullte… Lots of cool new biological insights. Great work from grad student @JoryGoldsmith in collaboration with @maynard_lab!
5
21
2
88
In the past week, there's been a flurry of new, informative reports on #LongCovid. I've tried to summarize them here along with the implications erictopol.substack.com/p/som… (PS you can subscribe, it's free)
42
587
52
1,531
Attending #ICEID2022? Lauren Ancel Meyers @laurenmeyers @UTPandemics discusses pathogen wargaming and pandemic preparedness 🔬 Wed. 4:30 p.m. Centennial Ballroom IV Hope to see you there! @TexasScience @MeyersLab @CDCgov
4
5
Quick summary on BA.4/5 variants @bmj_latest bmj.com/content/378/bmj.o196… by @emahase_ w/ @chrischirp @SGriffin_Lab @PeacockFlu <-Key point on identical spike for these 2 variants but marked growth advantage for BA.5, shows how little we know about non-spike effects
5
94
4
244
BA.4/BA.5 🔬scenario projections by @UTPandemics 🔬 @KXAN_News @GraceReaderTV highlighted the findings @TexasScience @meyerslab https://teapawt.net/t.co/kIDURlZT4z
3
4
Very interesting preprint in @medrxivpreprint discussing the "double-edged sword" of asymptomatic COVID infections. While they may improve individual-level outcomes by reducing ⏬severe cases, they ⏫increase overall population-level outcomes. Nice work all @sang_woo_park
This Post is from an account that no longer exists. Learn more
1
3